Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/1/2026

Initial Evaluation of Hypertension in Young Adults

Basic Laboratory Testing

  • The American College of Cardiology recommends ordering a comprehensive metabolic panel, complete blood count, lipid profile, thyroid-stimulating hormone, urinalysis with urine albumin-to-creatinine ratio, and a 12-lead electrocardiogram for an 18-year-old male with elevated blood pressure 1, 2, 3
  • Fasting blood glucose testing is recommended to identify diabetes mellitus, which significantly increases cardiovascular risk and lowers treatment thresholds 1, 2, 4
  • Complete blood count is recommended to detect anemia or other hematologic abnormalities 1, 2
  • Lipid profile is recommended for cardiovascular risk stratification 1, 2, 4
  • Serum creatinine with estimated glomerular filtration rate (eGFR) is recommended to assess kidney function and detect chronic kidney disease 1, 2, 3, 5
  • Serum sodium, potassium, and calcium testing is recommended to detect electrolyte abnormalities that may suggest secondary causes like primary aldosteronism 1, 2, 3
  • Thyroid-stimulating hormone testing is recommended to easily detect hypothyroidism and hyperthyroidism, both remediable causes of hypertension 1, 2, 3

Urine Tests

  • Urinalysis is recommended to screen for kidney disease 1, 2, 3
  • Urinary albumin-to-creatinine ratio is recommended rather than urine dipstick, as it is more sensitive for detecting early kidney damage and cardiovascular risk 5, 4

Cardiac Testing

  • A 12-lead electrocardiogram is recommended to detect left ventricular hypertrophy, arrhythmias (including atrial fibrillation), and ischemic heart disease 1, 2, 3, 4

Special Considerations

  • The American College of Cardiology recommends measuring thigh blood pressure in adults ≤30 years of age with elevated brachial blood pressure; if the thigh measurement is lower than arm pressures, coarctation of the aorta should be considered 2
  • Young patients with hypertension warrant heightened suspicion for secondary causes, particularly given the absence of typical risk factors like obesity, family history, or gradual onset 1, 6

Screening for Secondary Hypertension

  • Clinical clues suggesting secondary hypertension include age of onset <30 years, severe or resistant hypertension, absence of family history of hypertension, and abrupt onset rather than gradual increase 1, 2, 6
  • The European Society of Cardiology recommends measuring renin and aldosterone in all adults with confirmed hypertension, representing a significant change from traditional approaches 6

Optional Testing

  • An echocardiogram is recommended if ECG shows abnormalities, cardiac symptoms are present, or detection of left ventricular hypertrophy would influence treatment decisions 3, 4
  • Uric acid testing is recommended as part of the initial evaluation 1, 2, 3

Clinical Pitfalls to Avoid

  • The American Journal of Kidney Diseases recommends using urine albumin-to-creatinine ratio instead of urine dipstick alone for albuminuria screening, as it is more sensitive for detecting early kidney damage 5
  • The American College of Cardiology recommends not skipping the ECG, as it is essential for detecting left ventricular hypertrophy and arrhythmias even in young patients 1, 2, 3
  • The American College of Cardiology recommends not overlooking secondary causes in young patients; the prevalence is higher than in older adults with gradual-onset hypertension 6
  • The American College of Cardiology recommends confirming hypertension with repeated measurements before extensive workup, but not delaying basic laboratory testing once hypertension is confirmed 1, 2

Laboratory Evaluation for Hypertension

Guideline-Based Recommendations

  • The European Society of Hypertension and European Society of Cardiology recommend including hemoglobin and/or hematocrit as part of routine testing for all hypertensive patients 7, 8
  • The European Society of Cardiology recommends measuring serum creatinine, eGFR, and urine ACR in all patients with hypertension, with ECG as standard testing 9, 10
  • The American College of Cardiology is not the source of this fact, however, the 2013 ESH/ESC Guidelines explicitly list "Haemoglobin and/or haematocrit" as a routine test for all hypertensive patients 7, 8

Special Populations

  • For women with chronic hypertension in pregnancy, a full blood count is explicitly recommended at first diagnosis to establish baseline values, which becomes critical for detecting superimposed preeclampsia 11

Comprehensive Initial Workup

  • The complete routine laboratory panel for hypertension typically includes lipid profile (total cholesterol, LDL, HDL, triglycerides) 7

Baseline Evaluation Prior to Initiating Amlodipine for Hypertension

Kidney Function Assessment

  • Measure serum creatinine and calculate estimated glomerular filtration rate (eGFR) to establish baseline kidney function and identify chronic kidney disease. 12, 13, 14

Electrolyte & Metabolic Assessment

  • Check serum sodium, potassium, and calcium to uncover electrolyte disturbances that may point to secondary causes such as primary aldosteronism. 12, 14, 15
  • Obtain a fasting blood glucose level to screen for diabetes mellitus, a major cardiovascular risk enhancer that influences antihypertensive treatment thresholds. 12, 16, 14, 15

Hematologic Assessment

  • Perform a complete blood count (including hemoglobin and hematocrit) to detect anemia or other hematologic abnormalities that can affect blood pressure control. 12, 13, 15

Cardiovascular Risk Stratification

  • Order a lipid profile (total cholesterol, LDL‑C, HDL‑C, triglycerides) to quantify a patient’s atherosclerotic risk and guide therapy intensity. 12, 13, 14, 15
  • Measure thyroid‑stimulating hormone to identify hypo‑ or hyper‑thyroidism, both reversible contributors to hypertension. 12, 14, 15

Urine Albuminuria Screening

  • Use urine albumin‑to‑creatinine ratio (UACR) rather than dipstick alone because it is more sensitive for early kidney injury and associated cardiovascular risk. 12, 13
  • A UACR result in the moderately elevated range signals increased cardiovascular risk and warrants closer monitoring. 12
  • Detecting albuminuria can influence drug selection; agents that block the renin‑angiotensin system (ACE inhibitors or ARBs) provide added benefit in patients with elevated albumin excretion. 12, 16

Cardiac Testing

  • Obtain a 12‑lead electrocardiogram to identify left ventricular hypertrophy, arrhythmias (including atrial fibrillation), and underlying ischemic heart disease. 12, 13, 14, 15

Additional Context‑Specific Testing

  • Consider transthoracic echocardiography when the ECG shows abnormalities, cardiac murmurs are present, symptoms suggest structural disease, or confirmation of left ventricular hypertrophy would alter management. 12, 13
  • Evaluate serum uric acid in the initial work‑up, especially in patients with resistant hypertension. 12, 15
  • If fasting glucose is elevated, obtain a hemoglobin A1c to confirm or rule out diabetes mellitus. 13, 14, 15

Special Populations

  • In women of childbearing potential, baseline pregnancy testing should be considered before starting or modifying amlodipine‑based regimens. 16

Clinical Pitfalls to Avoid

  • Do not omit the baseline ECG, even in younger adults, because it is essential for detecting left ventricular hypertrophy and arrhythmias. 13
  • Do not rely solely on urine dipstick for albuminuria screening; always order a quantitative UACR. 12
  • Actively look for clues of secondary hypertension during the initial evaluation—hypokalemia may indicate primary aldosteronism, and an elevated creatinine level may suggest underlying renal disease. 12, 17

REFERENCES

4

Diagnostic Approach to Chronic Uncontrolled Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Secondary Causes of Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025